Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

0 of 0 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

2(33.3%)

Phase 3

2(33.3%)

Phase 2

1(16.7%)

Phase 1

1(16.7%)

6Total

N/A(2)

Phase 3(2)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT07087314Phase 2Recruiting

A Study of Anti-CD38 Monoclonal Antibody (SG301) Subcutaneous Injection in Children With Nephrotic Syndrome With Frequent Relapses or Steroid Dependence

Role: lead

NCT07388810Not ApplicableNot Yet Recruiting

Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome

Role: lead

NCT06789107Phase 1Recruiting

Blinatumomab in Refractory Active Childhood Systemic Lupus Erythematosus

Role: lead

NCT06079788Phase 3Recruiting

Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized，Open-label Clinical Trial.

Role: lead

NCT04925011Phase 3Unknown

Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD

Role: lead

NCT03199508Not ApplicableUnknown

Clinical Values of Voiding Diary for Diagnosis and Treatment for Monosymptomatic Enuresis in Children

Role: lead

All 6 trials loaded